ACADIA Pharmaceuticals Announces Publication of Data from Its -015 Open Label Safety Study in Parkinson’s Disease Psychosis in the Journal of the American Medical Directors Association
Go back to ACADIA Pharmaceuticals Announces Publication of Data from Its -015 Open Label Safety Study in Parkinson’s Disease Psychosis in the Journal of the American Medical Directors Association| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 26.40 -0.89 (3.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.29 | 52 Week High | $42.49 | |||
| Open | $27.43 | 52 Week Low | $16.64 | |||
| Day High | $27.43 | P/E | N/A | |||
| Day Low | $26.34 | EPS | $-0.42 | |||
| Volume | 1,351,979 | |||||
